BioMarin Pharmaceutical Inc. Stock Forecast
Red day on Wednesday for BioMarin Pharmaceutical Inc.
(Updated on Apr 24, 2024)
The BioMarin Pharmaceutical Inc. stock price fell by -0.93% on the last day (Wednesday, 24th Apr 2024) from $92.06 to $91.20. During the last trading day the stock fluctuated 2.20% from a day low at $91.01 to a day high of $93.02. The price has fallen in 6 of the last 10 days but is still up by 1.1% over the past 2 weeks. Volume has increased on the last day by 290 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $142.12 million.
The stockis at the upper part of a horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at $92.23 will give a strong buy signal and a trend shift could be expected. Given the current horizontal trend, you can expect BioMarin Pharmaceutical Inc. stock with a 90% probability to be traded between $83.94 and $92.33 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BMRN Signals & Forecast
The BioMarin Pharmaceutical Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $90.40 and $87.57. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -1.11%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock
BioMarin Pharmaceutical Inc. finds support from accumulated volume at $90.87 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $2.01 (2.20%) between high and low. For the last week, the stock has had daily average volatility of 1.89%.
Our recommended stop-loss: $88.51 (-2.95%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 8 days ago.)
Trading Expectations (BMRN) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect BioMarin Pharmaceutical Inc. to open at $91.74, and during the day (based on 14 day Average True Range), to move between $89.41 and $92.99, which gives a possible trading interval of +/-$1.79 (+/-1.96%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 3.92% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $91.24 (0.04%) than the support at $90.87 (0.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
BioMarin Pharmaceutical Inc. will release earnings AMC on Wednesday, April 24, 2024.The consensus among the analysts for the expected earnings (EPS) is $0.600. We will update the financials statements for BioMarin Pharmaceutical Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 2.70% in the first trading day after earnings release.
Is BioMarin Pharmaceutical Inc. stock A Buy?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for BioMarin Pharmaceutical Inc. stock to perform well in the short-term period.
Current score: 2.411 Buy Candidate Unchanged
Predicted Opening Price for BioMarin Pharmaceutical Inc. of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $91.74 ( 0.594%) | $91.20 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BMRN
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 93.75 | 2.79 % | |
| R2 | 92.98 | 1.95 % | ||
| R1 | 92.51 | 1.43 % | ||
| Current price: | 91.20 | |||
| Support | S1 | 90.98 | -0.246 % | |
| S2 | 90.50 | -0.765 % | ||
| S3 | 89.74 | -1.60 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 92.22 | 1.12 % | |
| R2 | 91.46 | 0.285 % | ||
| R1 | 91.24 | 0.0439 % | ||
| Current price | 91.20 | |||
| Support | S1 | 90.87 | -0.362% | |
| S2 | 89.66 | -1.69% | ||
| S3 | 86.28 | -5.39% |
FAQ
Click here for our free guide on how to buy BioMarin Pharmaceutical Inc. Stock.
